OMER

Omeros Corporation Press Releases

$15.5
*  
0.26
1.65%
Get OMER Alerts
*Delayed - data as of Aug. 28, 2015  -  Find a broker to begin trading OMER now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Omeros Announces Additional Positive Data in OMS721 Phase 2 Clinical Trial
8/18/2015 7:00:00 AM - PR Newswire
▲6.53 % Price Change since this news event. The Volume Ratio is 35.65.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Omeros Announces Plan to File Infringement Suit Against ANDA Filer
8/17/2015 7:00:00 AM - PR Newswire
▲14.81 % Price Change since this news event. The Volume Ratio is 0.61.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Omeros Corporation Reports Second Quarter 2015 Financial Results
8/10/2015 4:11:00 PM - PR Newswire
▲1.97 % Price Change since this news event. The Volume Ratio is 2.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Omeros to Present at the 2015 Wedbush PacGrow Healthcare Conference
8/7/2015 7:00:00 AM - PR Newswire
▲4.59 % Price Change since this news event. The Volume Ratio is 1.22.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Omidria® Approved for Commercialization Throughout the European Union and Additional Countries
8/3/2015 7:00:00 AM - PR Newswire
▼-3.73 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Omeros Corporation to Announce Second Quarter 2015 Financial Results on August 10, 2015
7/31/2015 4:50:00 PM - PR Newswire
▼-3.73 % Price Change since this news event. The Volume Ratio is 0.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


FDA Grants "Fast Track" to Omeros' Complement Inhibitor OMS721 for aHUS
7/23/2015 7:00:00 AM - PR Newswire
▼-13.12 % Price Change since this news event. The Volume Ratio is 1.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Rajiv Shah, M.D., Appointed to Omeros'' Board of Directors
6/17/2015 7:00:00 AM - PR Newswire
▼-21.95 % Price Change since this news event. The Volume Ratio is 1.67.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Omeros Announces Exclusive License Agreement for Omeros' Arthroscopic Product OMS103
6/16/2015 7:00:00 AM - PR Newswire
▼-20.80 % Price Change since this news event. The Volume Ratio is 1.44.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day